医学
麻醉
迷走神经电刺激
针灸科
临床试验
迷走神经
梅德林
神经刺激
外科
随机对照试验
刺激
物理疗法
止痛药
神经刺激器
作者
Marcos Lisboa Neves,Bernardo Diniz Coutinho,Guilherme Fleury Fina Speretta,Scheila Iria Kraus,Jeane Bachi Ferreira,Pedro André H Amaral,Juliana Elizabete Dos Santos Bud,Ana Merian da Silva,Vinícius Alexandre Wippel,Igor Kunze Rodrigues,Marta Maria Medeiros Frescura Duarte,Jocemar Ilha,Morgana Duarte da Silva
出处
期刊:Pain Medicine
[Oxford University Press]
日期:2026-01-27
卷期号:27 (7): 804-813
被引量:2
摘要
BACKGROUND: Auricular vagus nerve stimulation (aVNS) has emerged as a noninvasive neuromodulatory strategy with the potential to modulate central sensitization and inflammatory pathways. However, its role in fibromyalgia (FM) remains insufficiently explored. OBJECTIVE: To investigate whether stimulation laterality (left vs right auricular branch of the vagus nerve) differentially influences clinical and biological outcomes in women with FM. METHODS: In this randomized, double-blind, sham-controlled trial, 51 women with FM were allocated to sham stimulation, right-sided aVNS (aVNS-R), or left-sided aVNS (aVNS-L). Participants underwent weekly sessions for 4 weeks and were followed for 12 weeks. Pain intensity was the primary outcome. Secondary outcomes included psychological symptoms, sleep, functional status, quality of life, and circulating biomarkers (pro- and anti-inflammatory cytokines, brain-derived neurotrophic factor [BDNF]). RESULTS: While no significant between-group differences were observed in pain intensity, left-sided stimulation (aVNS-L) was associated with a modest but significant reduction in global symptom severity. Importantly, aVNS-L produced consistent immunomodulatory effects, including decreased IL-1β and TNF-α levels, and increased IL-4, IL-10, and BDNF concentrations. CONCLUSIONS: This exploratory trial suggests that stimulation laterality may shape the biological response to aVNS in FM. Although clinical pain relief was not superior to sham, left-sided stimulation promoted an anti-inflammatory profile and enhanced neuroplasticity markers. These findings support further investigation of aVNS laterality as a targeted neuromodulatory approach for FM. TRIAL REGISTRATION: Brazilian Clinical Trials Registry RBR-10d3crcf.
科研通智能强力驱动
Strongly Powered by AbleSci AI